Frequent c-Ki-ras Oncogene Activation in Mucous Cell Hyperplasias of Pancreas Suffering from Chronic Inflammation

Cancer Research

Volumn 53, Issue 5, 1993, Pages 953-956

  Yanagisawa, Akio ^a   Ohtake, Keiko ^a   Ohashi, Kazuhiko ^a   Hon, Masaharu ^a   Kitagawa, Tomoyuki ^a   Sugano, Haruo ^a   Kato, Yo ^a  

^a CANCER INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CELL HYPERPLASIA; CHRONIC PANCREATITIS; DNA DETERMINATION; DOT HYBRIDIZATION; GENE ACTIVATION; GENE AMPLIFICATION; HUMAN; HUMAN TISSUE; MALIGNANT TRANSFORMATION; MUCOUS CELL; ONCOGENE RAS; PAPILLARY CARCINOMA; POINT MUTATION; POLYMERASE CHAIN REACTION; PRECANCER; PRIORITY JOURNAL;

ADULT; AGED; BASE SEQUENCE; CHRONIC DISEASE; FEMALE; GENE EXPRESSION REGULATION; GENES, RAS; HUMAN; HYPERPLASIA; MALE; MIDDLE AGE; MOLECULAR SEQUENCE DATA; PANCREAS; PANCREATITIS; POINT MUTATION; SUPPORT, NON-U.S. GOV'T;

EID: 0027502624     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Cubilla, A.L., and Fitzgerald, P.J. Morphological lesions associated with human primary invasive nonendocrine pancreas cancer. Cancer Res., 36: 2690-2698, 1976.
2. Sommers, S.C., Murphy, S.A., and Warren, S. Pancreatic duct hyperplasia and cancer. Gastroenterology, 27: 629-640, 1954.
3. Kozuka, S., Sassa, R., Taki, T., Masamoto, K., Nagasawa, S., Saga, S., Hasegawa, K., and Takeuchi, M. Relation of pancreatic duct hyperplasia to carcinoma. Cancer (Phila.), 43: 1418-1428, 1979.
4. Birnstingl, M. A study of pancreatography. Br. J. Surg., 46: 128-139, 1959.
5. Klöppel, G., Bommer, K., Rücken, K., and Seifert, G. Intraductal proliferation in the pancreas and its relationship to human and experimental carcinogenesis. Virchows Arch. A Pathol. Anat. Histol., 387: 221-233, 1980.
6. Almoguera, C., Shibata, D., Forrester, K., Martin, J., Arnheim, N., and Perucho, M. Most human carcinomas of the exocrine pancreas contain mutant c-K-rar genes. Cell, 53: 549-554, 1988.
7. Smit, V.T.H.B.M., Boot, A.J.M., Smits, A.M.M., Flueren, G.J., Cornelisse, C.J., and Bos, J.L. KRAS codon 12 mutations occur very frequently in pancreatic adenocarcinomas. Nucleic Acids Res., 16: 7773-7782, 1988.
8. Tada, M., Omata, M., and Ohto, M. Clinical application of ras gene mutation for diagnosis of pancreatic adenocarcinoma. Gastroenterology, 100: 233-238, 1991.
9. Mariyama, M., Kishi, K., Nakamura, K., Obata, H., and Nishimura, S. Frequency and types of point mutation at the 12th codon of the c-Ki-rar gene found in pancreatic cancers from Japanese patients. Jpn. J. Cancer Res., 80: 622-626, 1989.
10. Grüneward, K., Lyons, J., Fröhlich, A., Feichtinger, H., Weger, R.A., Schwab, G., Janssen, J.W.G., and Bartram, CR. High frequency of Ki-ras codon 12 mutations in pancreatic adenocarcinomas. Int. J. Cancer, 43: 1037-1041, 1989.
11. Yanagisawa, A., Kato, Y., Sugano, H., Ohashi, K., Takekoshi, T., and Takagi, K. Classification of the pancreatic cyst with atypical epithelium. Biliary tract (in Japanese). Pancreas, 5: 1079-1085, 1984.
12. Yanagisawa, A., Ohashi, K., Hori, M., Takagi, K., Kitagawa, T., Sugano, H., and Kato, Y. Ductectatic type mucinous cystadenoma and cystadenocarcinoma of the human pancreas: A novel clinicopathological entity. Jpn. J. Cancer Res., 84: in press, 1993.
13. Yanagisawa, A., Kato, Y., Ohtake, K., Ohashi, K., Hori, M., Takagi, K., and Sugano, H. c-Ki -ras point mutation in ductectatic-type mucinous cystic neoplasms of the pancreas. Jpn. J. Cancer Res., 82: 1057-1060, 1991.
14. Saiki, R.K., Scharf, S., Faloona, F., Mullis, K.B., Horn, G.T., Erlich, H.A., and Arnheim, N. Enzymatic amplification of ß-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science (Washington DC), 230: 1350-1354, 1985.
15. Wright, D.K., and Manos, M.M. Sample preparation from paraffin-embedded tissues. In: I.A. Michael (ed.), PCR Protocols: A Guide to Methods and Applications, pp. 153-158. New York: Academic Press, 1990.
16. Verlaan-de Vries, M., Bogaard, M.E., Elst, H., Boom, J.H., Eb, A.J., and Bos, J.L. A dot-blot screening procedure for mutated ras oncogenes using synthetic oligode-oxynucleotides. Gene, 50: 313-320, 1986.
17. Bos, J.L., Fearon, E.R., Hamilton, S.R., and Verlaan-de Vries, M. Prevalence of ras gene mutations in human colorectal cancers. Nature (Lond.), 327: 293-297, 1987.
18. Vogelstein, B., Fearon, E.R., Hamilton, S.R., Kem, S.E., Preisinger, A.C., Leppert, M., Nakamura, Y., White, R., Smits, A.M.M., and Bos, J.L. Genetic alterations during colorectal-tumor development. N. Engl. J. Med., 319: 525-532, 1988.
19. Forrester, K., Almoguera, C., Hank, K., Grizzle, W.E., and Perucho, M. Detection of high incidence of K-ras oncogenes during human colon tumorigenesis. Nature (Lond.), 327: 298-303, 1987.
20. Padura, R., Cater, G., Hughes, D., Gow, J., Farr, C.J., Oscier, D., McCormick, F., and Jacobs, A. RAS mutations in myelodysplasia detected by amplification, oligonucleotide hybridisation and transformation. Leukemia (Baltimore), 2: 503-510, 1988.
21. Lemoine, N.R., Jain, S., Hughes, C.M., Staddon, S.L., Maillet, B., Hall, P.A., and Klöppel, G. Ki-ras oncogene activation in preinvasive pancreatic cancer. Gastroenterology, 102: 230-236, 1992.
22. Cerny, W.L., Mangold, K.A., and Scarpelli, D.G. K-ras mutation is an early event in pancreatic duct carcinogenesis in the Syrian golden hamster. Cancer Res., 52: 4507-4513, 1992.
23. Nagata, Y., Abe, M., Motoshima, K., Nakayama, E., and Shiku, H. Frequent glycine-to-aspartic acid mutations at codon 12 of c-Ki-ros gene in human pancreatic cancer in Japanese. Jpn. J. Cancer Res., 81: 135-140, 1990.